ACE Inhibitors And Diabetes In Blacks
The class of drugs known as ACE (angiotensin-converting enzyme) inhibitors, already shown to slow kidney disease among African-Americans with hypertension, have the additional advantage of reducing the risk of developing diabetes in blacks. That's the conclusion of UAB nephrologist Denyse Thornley-Brown, M.D., and colleagues in the current Archives of Internal Medicine. "Historically, people felt ACE inhibitors were not beneficial to blacks, but our analysis of the large, ongoing African-American Study of Kidney Disease and Hypertension showed the ACE inhibitor ramipril to be half as likely to cause diabetes mellitus, compared to beta-blockers and calcium channel blockers." Previous studies of ACE inhibitors in hypertensives did not differentiate effects based on race.
Print-friendly Layout